PLD6 and breast carcinoma: There is evidence that implicates ELOVL5 (61), DHCR7 (71), ACOT7 (72), ME1 (73), ACACB (74), FASN (75), ACSL6 (76), CPT1B (77), FAAH (78), ANGPTL4 (79), STARD3 (80), SRD5A1 (81), HSD171B (82), NCOA1 (83), UGT8 (40), INPP4B (84), DGAT2 (85), MBOAT1 (86), PTGR1 (87), and PLD6 (88) in breast cancer prognosis.